STUDY DESIGN: Retrospective cohort study of all pregnant women with pregestational DM at a single tertiary institution (1/03-1/17) whose pregnancies reached at least 20 weeks' gestation. The primary outcome was frequency of major or minor congenital anomalies as assessed by ultrasound, pathology, and newborn examination (excluding known aneuploidy). Periconception HbA1C, defined as HbA1C within three months of conception, was assessed as a continuous variable and by category (HbA1C 7.4%, 7.5 e 9.4%, 9.5 e 11.4%, and 11.5%). The association of HbA1C with anomalies was analyzed using bivariable and multivariable analyses. RESULTS: Of 416 eligible women with pregestational DM, 65.5% had type 2 DM and 29.8% were non-Hispanic black. Nearly 1 in 6 (16.5%) women had a fetal anomaly. The majority of anomalies (75.4%) were classified as major and almost half of those (47.4%) were cardiovascular. The median HbA1C of women with fetal anomalies was significantly greater than that of women without anomalies (8.2% vs. 6.6%, p<0.001). The adjusted odds of anomaly increased significantly with each percentage point increase in HbA1c (aOR 1.47; 95% CI 1.27-1.69). Women with HbA1C 11.5% had a nearly 45% frequency of any anomaly ( Figure) and significantly increased adjusted odds of anomalies compared to women with HbA1c 7.4% (Table) . Women with HbA1C 7.5-9.4% and 9.5-11.4% also demonstrated similarly high frequencies of anomalies (19.7% and 33.3%, respectively) ( Table) . Compared to women with the HbA1C 7.4%, women with HbA1C 11.5% were significantly more likely to be younger (RRR 0.92, 95% CI 0.85-0.99) and nonHispanic black (RRR 13.23, . CONCLUSION: In a diverse cohort of women with pregestational DM, higher periconception HbA1C is significantly associated with congenital fetal anomalies. The frequency of anomalies is higher than reported in older literature, and identified to be as high as nearly 1 in 2 women with the poorest glycemic control.
Early hemoglobin A1c as a screening test for gestational diabetes among overweight and obese women
Amy Caldwell, Annessa Kernberg, Amy Valent, Kyle Hart
Oregon Health and Science University, Portland, OR OBJECTIVE: Overweight and obese pregnant woman are known to be at increased risk of developing gestational diabetes. However, little is known about early screening in this population. The objective of this study was to determine early (< 20 gestational age) hemoglobin A1c values between overweight and obese pregnant women who develop gestational diabetes (GDM) compared those who do not develop GDM. STUDY DESIGN: A case-control study comparing overweight and obese women with GDM to overweight and obese women without GDM (non-GDM) in a 3:1 ratio between 2011 and 2014 at Oregon Health and Sciences University to determine if early hemoglobin A 1C (HbA 1C ; obtained < 20 weeks gestational age) differs between the two cohorts. Chi squared, Pearson correlation, and Wilcoxon ranksum test were used to compare GDM and non-GDM pregnancies. Receiver Operating Characteristic (ROC) curve was analyzed to plot the true positive rate against the false positive rate for the different possible cut-points of early HbA 1C to predict the diagnosis of GDM among overweight and obese women. RESULTS: A total of 443 subjects were analyzed (n¼139 cases and n¼304 controls). Women with GDM were more likely to be nonwhite, older in age, multiparous and have a higher pre-pregnancy BMI (see Table) . Women with GDM had a significant difference in early HbA 1C compared to non-GDM pregnancies (5.6 and 5.3%, P<0.01). Early HbA 1C is more significantly correlated with GDM diagnosis than pre-pregnancy BMI (0.34 vs 0.13; p<0.01). The curve point at which the area under the ROC curve was maximized was an early HbA 1C of 5.6% with an AUC ¼ 0.725 (see Figure) . CONCLUSION: Overweight and obese women who develop GDM have significantly different HbA 1C than non-GDM pregnancies. The mean HbA 1C is lower than the American Diabetes Association definition for pre-diabetes. When using A1c as a screening tool, these data suggest lower cut-points should be considered among overweight and obese pregnant women to perform early diagnostic diabetes testing in pregnancy. However, further studies are needed to determine a reliable, predictive HbA 1C . 
OBJECTIVE:
To quantify the magnitude of the association between maternal diabetes (DM) and severe neonatal morbidity and mortality. STUDY DESIGN: Retrospective cohort study of women with a nonanomalous singleton who delivered between 24 0/7 and 41 6/7 weeks' gestation from two large U.S. databases: MFMU Cesarean Registry (1999) (2000) (2001) (2002) and Consortium on Safe Labor (2002) (2003) (2004) (2005) (2006) (2007) (2008) . The primary exposure was DM status: pregestational type 1 or 2 DM vs GDM vs no DM. The primary outcome was a composite of severe neonatal morbidity including RDS, mechanical ventilation, NEC, grade 3 or 4 IVH, and neonatal death. Multivariable logistic regression was used to estimate the association between DM and severe neonatal morbidity with three main comparisons: pregestational DM vs no DM, pregestational DM vs GDM, and GDM vs no DM. RESULTS: 196,397 subjects met inclusion criteria: 63,929 (32.6%) from the Cesarean Section Registry and 132,468 (67.5%) from the Consortium on Safe Labor. Among these, 10,564 (5.4%) had GDM and 3,008 (1.5%) had pregestational DM. Compared to non-diabetic women, those with GDM and pregestational DM were older, had higher BMI, more medical comorbidities (chronic hypertension, cardiac disease, renal disease), more pregnancy complications (gestational hypertension or preeclampsia, cesarean, LGA neonate), and were more likely to be delivered at an earlier gestational age (Table 1) . Pregestational DM was associated with higher adjusted odds of severe neonatal morbidity, compared to no DM and compared to GDM (Table 2 ). In contrast, there was no significant association between GDM and severe neonatal morbidity, compared to no DM. Similar relationships were observed for certain components of this composite, RDS and mechanical ventilation, as well as NICU admission. In addition, GDM was associated with a higher adjusted odds of NICU admission, compared to no DM. Using the final multivariable logistic regression model, the estimated probability of severe neonatal morbidity was 6.7% (95% CI 6.6-6.8%) among women without DM, 9.7% (95% CI 9.3-10.0%) among women with GDM, and 13.7% (95% CI 12.8-14.6%) among women with pregestational DM. CONCLUSION: Neonates born to women with pregestational DM were more likely to have severe morbidity and mortality, compared to those without DM and to those with GDM. Differences in severe neonatal morbidity and mortality were not appreciated for women with GDM compared to those without DM, however, there was an association with NICU admission.
496 Missed opportunities for early screening of diabetes mellitus in pregnancy Ashley N. Battarbee, Maximilliano Cavallini, Catherine Keller, Kim Boggess University of North Carolina -Chapel Hill, Chapel Hill, NC OBJECTIVE: To identify characteristics of women at risk for overt diabetes at < 21 weeks' gestation that fail to receive recommended early pregnancy diabetes screening. STUDY DESIGN: Retrospective cohort study of pregnant women < 21 weeks' gestation who initiated prenatal care at single, tertiary care center from January 2015 to December 2015. Based on the 2013
